Neuromuscular Blocking AGENTS .

dc.contributor.authorEssam, Takwa
dc.date.accessioned2020-04-06T08:00:34Z
dc.date.available2020-04-06T08:00:34Z
dc.date.issued2020-04-05
dc.descriptionThese drugs block cholinergic transmission between motor nerve endings and the nicotinic receptors on the skeletal muscle. They possess some chemical similarities to ACh, and they act either as antagonists (nondepolarizing type) or as agonists (depolarizing type) at the receptors on the endplate of the NMJ.en_US
dc.identifier.urihttp://repository.limu.edu.ly/handle/123456789/1383
dc.language.isoenen_US
dc.publisherFaculty of pharmacyen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.titleNeuromuscular Blocking AGENTS .en_US
dc.title.alternativeoral presentation /2nd year /Block VIIen_US
dc.typePresentationen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2019-Medical-Plan-PowerPoint-Templates.pdf
Size:
8.33 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.74 KB
Format:
Item-specific license agreed upon to submission
Description: